PROVIDER PROFILE · NPI 1538336151
Louisa ZiglarMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
4,934
Unique beneficiaries
—
Total services
20,448
Distinct HCPCS
55
Medicare payment
$375K
Peer benchmark
Total Medicare services vs. 133 Rheumatology providers in MD — above median (cohort median 27,542).
PRESCRIBING · PART D · 2024
Total Rx claims
1,669
Beneficiaries
—
Total drug cost
$940K
Distinct drugs
30
Brand share
26.2%
Top prescribed drugs
Methotrexate Sodium267 claims
Hydroxychloroquine Sulfate209 claims
Prednisone207 claims
Alendronate Sodium205 claims
Tramadol Hcl70 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$118
Payment records
4
By payment type
Education$69
Food and Beverage$49
Top paying entities
Education$69
Food and Beverage$49
REFERRAL NETWORK
Where Louisa Ziglar's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Sunrise Medical Laboratories, Inc. Clinical Laboratory · Hicksville, NY | 56 | 225 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 18 | 38 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE